STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. SXTC
  4. [EFFECT] China SXT Pharmaceuticals, Inc. SEC Filing

[EFFECT] China SXT Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 14, 2025
Accession Number: 0001213900-25-108213
Submission Type: POS AM
CIK: 0001723980
Company Name: China SXT Pharmaceuticals, Inc.
File Number: 333-282776

Source: View Original Filing on SEC EDGAR

Stock SXTC logo
China Sxt Pharmaceuticals Inc

NASDAQ:SXTC

SXTC Rankings

#4545 Ranked by Market Cap
N/A Ranked by Dividends

SXTC Latest News

Mar 17, 2025
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency
Feb 21, 2025
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Oct 7, 2024
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
Oct 26, 2023
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule
Oct 4, 2023
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split

SXTC Latest SEC Filings

Nov 10, 2025
[F-3] China SXT Pharmaceuticals, Inc. Foreign Issuer Shelf Registration
Nov 10, 2025
[POS AM] China SXT Pharmaceuticals, Inc. SEC Filing
Aug 7, 2025
[SCHEDULE 13G] China SXT Pharmaceuticals, Inc. SEC Filing
Aug 7, 2025
[SCHEDULE 13G] China SXT Pharmaceuticals, Inc. SEC Filing
Aug 7, 2025
[SCHEDULE 13G] China SXT Pharmaceuticals, Inc. SEC Filing

SXTC Stock Data

164.76M
75.04M
35.33%
0.07%
0.04%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
China
Taizhou